NASDAQ:MBRX
Moleculin Biotech Inc Stock News
$4.76
-0.0200 (-0.418%)
At Close: May 10, 2024
Moleculin Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 15, 2020
11:30am, Friday, 08'th May 2020
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today annou
SEC Puts the Kibosh on 3 Biotech Stocks Hawking a Miracle Anti-Coronavirus Drug
12:39pm, Wednesday, 06'th May 2020
Since early February, the U.S. Securities and Exchange Commission has issued a series of warnings to investors to beware of companies hawking miracle cures to the disease known as COVID-19. Surely eve
SEC Puts the Kibosh on 3 Penny Stocks Hawking a Miracle Anti-Coronavirus Drug
12:35pm, Wednesday, 06'th May 2020
Since early February, the U.S. Securities and Exchange Commission has issued a series of warnings to investors to beware of companies hawking miracle
Moleculin Biotech, Inc. (MBRX) Flat As Market Gains: What You Should Know
09:45pm, Tuesday, 05'th May 2020
Moleculin Biotech, Inc. (MBRX) closed the most recent trading day at $1.07, making no change from the previous trading session.
Stocks surge as more states move to reopen amid coronavirus
07:11pm, Tuesday, 05'th May 2020
JP Morgan Private Bank Head of Cross-Asset Thematic Strategy Anastasia Amoroso joins Yahoo Finance’s Seana Smith to discuss the latest market action as more states move to reopen their economies in
SEC takes action against three more companies over COVID-19 claims
07:09pm, Tuesday, 05'th May 2020
The Securities and Exchange Commission temporarily halted trading in three more stocks on Monday because of questions regarding the accuracy of information in the marketplace about a drug candidate fo
Moleculin Announces Trading Halt
11:37pm, Monday, 04'th May 2020
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today annou
SEC takes action against three more companies over COVID-19 claims
07:51pm, Monday, 04'th May 2020
The Securities and Exchange Commission temporarily halted trading in three more stocks on Monday because of questions regarding the accuracy of information...
Moleculin to Speak on COVID-19 Panel at Maxim Group's Infectious Disease Virtual Conference
11:30am, Wednesday, 29'th Apr 2020
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today annou
The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt
11:53am, Thursday, 23'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks htitting 52-week highs April 22.) * Dr.Reddy's Laboratories Ltd (NYSE: RDY) * Johns
EXEL, TNK among premarket gainers
01:08pm, Monday, 20'th Apr 2020
Avalon GloboCare (NASDAQ:AVCO) +44% on advancing immunotherapeutic program towards combatting cytokine storm associated with COVID-19 lung damage and mortality.Safe-T Group Ltd (NASDAQ:SFET) +41% on
INO, BBBY among premarket gainers
01:19pm, Thursday, 16'th Apr 2020
Edison Nation (NASDAQ:EDNT) +169% on over $10M order.Soligenix (NASDAQ:SNGX) +91% on deal for COVID-19 vaccine adjuvant.Atossa Therapeutics (NASDAQ:ATOS) +82% on launching COVID-19 HOPE drug devel
The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant
12:09pm, Thursday, 16'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) * Bio-Rad Laboratories, Inc. Class B Common Stock
Analysts Are Bullish on These Healthcare Stocks: Moleculin Biotech (MBRX), Axonics Modulation Technologies (AXNX)
07:07pm, Wednesday, 15'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Moleculin Biotech (MBRX) and Axonics Modulation
Analysts Are Bullish on These Healthcare Stocks: Moleculin Biotech (MBRX), Axonics Modulation Technologies (AXNX)
07:07pm, Wednesday, 15'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Moleculin Biotech (
MBRX
–
Research Report
) and Axonics Modulation Technologies (
AXNX
–
Research